BlueRun Ventures Continues to Back ONERWAY in $10 Million Series A+ Round, Advancing Global Payment Infrastructure to New Heights | BlueRun Family

On August 11, ONERWAY, a UK-headquartered global payments brand, completed a $10 million Series A+ round. The round was co-led by Yunqi Capital, Series A investor BlueRun Ventures, Eminence Ventures, and Vitalbridge Capital, reflecting strong market confidence in ONERWAY's continued growth.

BlueRun Ventures led ONERWAY's Series A round and doubled down in this round.

Since its founding in 2017, ONERWAY has been dedicated to providing secure, efficient cross-border payment solutions for businesses. This funding will help ONERWAY accelerate its global expansion and strengthen its cross-border payment infrastructure, delivering faster and more cost-effective payment processing capabilities. Additionally, ONERWAY plans to launch new AI-powered products such as stablecoin payments and proxy payments, further enriching its product portfolio. With robust technical capabilities and a global footprint, ONERWAY has become a leader in overseas corporate account solutions, providing payment services to global e-commerce platforms, game developers, and AIGC startups, supporting over 170 payment methods across 110 currencies, with seven global offices covering more than 60 countries and regions.

Andy Wang, co-founder and CEO of ONERWAY, said: "The swift completion of this round validates our strategy for rapid growth in a challenging market. We are not merely expanding — we are redefining how businesses transact on a global scale. This capital injection will further propel our mission to break down fragmented payments, reduce friction in cross-border transactions, and make global growth accessible to all businesses."

Going forward, ONERWAY will continue to use these funds to enhance its technology R&D, expand global licensing, and deepen strategic partnerships, providing more efficient payment solutions for merchants operating across borders. The company also plans to launch a Series B round in 2026 to further solidify its position as a leading global payments solution provider.

BlueRun Ventures Doubles Down as Muyang Bio Completes New Nine-Figure RMB Funding Round | BlueRun Portfolio BlueRun Ventures Doubles Down as Kunta Magnetic Levitation Completes Series A++ Round | BlueRun Portfolio BlueRun Ventures Leads Series A Round for Vision Care AR/VR Medtech Firm Revo Vision | BlueRun Portfolio